SCHEMBL925857

SCHEMBL925857

CSSNCC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6025541 0.75
SCHEMBL23015655 0.69
SCHEMBL6025538 0.67
SCHEMBL23543063 0.67
SCHEMBL20031203 0.67
SCHEMBL21531775 0.67
SCHEMBL925704 0.65
SCHEMBL23521071 0.65
SCHEMBL20097095 0.65 ADH1B (0.32)
Hydrochloric Acid SCHEMBL3896192 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2540320-A1 LEPTOMYCIN DERIVATIVES SANOFI (FR) 2013-01-02 EP disclosed
EP-2032172-B1 LEPTOMYCIN DERIVATIVES SANOFI SA (FR) 2012-06-06 EP disclosed
EP-2448929-A1 NOVEL CONJUGATES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-05-09 EP disclosed
US-20110002947-A1 LEPTOMYCIN DERIVATIVES SANOFI-AVENTIS (FR) 2011-01-06 US disclosed
WO-2011001052-A1 NOVEL CONJUGATES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-01-06 WO disclosed
US-7816543-B2 Leptomycin derivatives SANOFI-AVENTIS (FR) 2010-10-19 US disclosed
US-20090182038-A1 Leptomycin Derivatives SANOFI-AVENTIS (FR) 2009-07-16 US disclosed
EP-2032172-A2 LEPTOMYCIN DERIVATIVES Sanofi-Aventis (FR) 2009-03-11 EP disclosed
WO-2007144709-A2 LEPTOMYCIN DERIVATIVES SANOFI-AVENTIS (FR) 2007-12-21 WO disclosed
EP-1864682-A1 Leptomycin derivatives Sanofi-Aventis (FR) 2007-12-12 EP disclosed